Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
GSK-4524101 by GSK for Breast Cancer: Likelihood of Approval
GSK-4524101 is under clinical development by GSK and currently in Phase II for Breast Cancer. According to GlobalData, Phase II...
Data Insights
GSK-4524101 by GSK for Solid Tumor: Likelihood of Approval
GSK-4524101 is under clinical development by GSK and currently in Phase II for Solid Tumor. According to GlobalData, Phase II...